Devats India Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 02-01-2025
- Paid Up Capital ₹ 3.22 M
as on 02-01-2025
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.08 Cr
as on 02-01-2025
- Satisfied Charges ₹ 1.15 Cr
as on 02-01-2025
- Revenue -53.07%
(FY 2021)
- Profit -15.51%
(FY 2021)
- Ebitda 130.28%
(FY 2021)
- Net Worth 1.14%
(FY 2021)
- Total Assets -10.30%
(FY 2021)
About Devats India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.22 M.
The company currently has active open charges totaling ₹6.08 Cr. The company has closed loans amounting to ₹1.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vatsala Khurana and Vijay Khurana serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PTC065559
- Company No.
065559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Devats India Private Limited offer?
Devats India Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Pain Killers, Infusion Syringes & Supplies, Blood Collection Tubes, Orthopedic Implants, Medical Supplies, Surgical Disposables, Hospital Linen, Hospital Dressing, Surgical Dressing.
Who are the key members and board of directors at Devats India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Khurana  | Director | 17-Feb-1995 | Current |
| Vatsala Khurana | Director | 17-Feb-1995 | Current |
Financial Performance of Devats India.
Devats India Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 53.07% decrease. The company also saw a substantial fall in profitability, with a 15.51% decrease in profit. The company's net worth moved up by a moderate rise of 1.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devats India?
In 2021, Devats India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Troge Scientific Research India Private LimitedActive 11 years 11 monthsVijay Khurana is a mutual person
- Boulevard Projects Delhione Resident Welfare AssociationActive 5 years 10 months
Vijay Khurana is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Nov 2019 | ₹2.70 Cr | Open |
Others Creation Date: 16 Aug 2018 | ₹9.13 M | Open |
Federal Bank Limited Creation Date: 20 Mar 2006 | ₹2.00 M | Open |
How Many Employees Work at Devats India?
Unlock and access historical data on people associated with Devats India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devats India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devats India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
